• 1
    Garnick DW, Horgan CM, Hodgkin D, et al. Risk transfer and accountability in managed care organizations' carve-out contracts. Psychiatr Serv. 2001;52: 15029.
  • 2
    Grazier KL, Eselius LL. Mental health carve-outs: effects and implications. Med Care Res Rev. 1999;56 (suppl 2): 3759.
  • 3
    Escobar JI, Golding JM, Hough RL, Karno M, Burnam MA, Wells KB. Somatization in the community: relationship to disability and use of services. Am J Public Health. 1987;77: 83740.
  • 4
    Harlow K, Johnson R, Callen P. Comparison of physical health benefits utilization. Mental and physical health claimants, 1989 and 1990. J Occup Med. 1993;35: 27581.
  • 5
    Hansson L, Persson KB, Borgquist L. Patients with mental illness in primary health care. A long-term follow-up of health care utilization and contact patterns with psychiatric care. Scand J Prim Health Care. 1997;15: 12933.
  • 6
    Rost K, Zhang M, Fortney J, Smith J, Smith GR Jr. Expenditures for the treatment of major depression. Am J Psychiatry. 1998;155: 8838.
  • 7
    Meerding WJ, Bonneux L, Polder JJ, Koopmanschap MA, Van Der Maas PJ. Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study. BMJ. 1998;317: 1115.
  • 8
    Simon GE, Unutzer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv. 1999;50: 13038.
  • 9
    Druss BG, Rosenheck RA. Patterns of health care costs associated with depression and substance abuse in a national sample. Psychiatr Serv. 1999;50: 2148.
  • 10
    Katon WJ, Lin E, Russo J, Unutzer J. Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psychiatry. 2003;60: 897903.
  • 11
    Hunkeler EM, Spector WD, Fireman B, Rice DP, Weisner C. Psychiatric symptoms, impaired function, and medical care costs in an HMO setting. Gen Hosp Psychiatry. 2003;25: 17884.
  • 12
    Goetzel RZ, Anderson DR, Whitmer RW, Ozminkowski RJ, Dunn RL, Wasserman J. The relationship between modifiable health risks and health care expenditures. An analysis of the multi-employer HERO health risk and cost database. The Health Enhancement Research Organization (HERO) Research Committee. J Occup Environ Med. 1998;40: 84354.
  • 13
    Druss BG, Rohrbaugh RM, Rosenheck RA. Depressive symptoms and health costs in older medical patients. Am J Psychiatry. 1999;156: 4779.
  • 14
    Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25: 46470.
  • 15
    International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, U.S. Department of Health and Human Services; 1988.
  • 16
    U.S. Department of Labor: Bureau of Labor Statistics. Consumer Price Index. Available at: Accessed December 20, 2002.
  • 17
    Canaud M-C, Huber M, Lafortune G, Cerf KL, Morgan D, Thompson A. OECD Health Data 2002: A Comparative Analysis of 30 Countries. 4th ed. Paris: Organisation for Economic Cooperation and Development; 2002.
  • 18
    Lumley T, Diehr P, Emerson S, Chen L. The importance of the normality assumption in large public health data sets. Ann Rev Public Health. 2002;23: 15169.
  • 19
    Hansen MS, Fink P, Frydenberg M, Oxhoj ML. Use of health services, mental illness, and self-rated disability and health in medical inpatients. Psychosom Med. 2002;64: 66875.
  • 20
    Fischer LR, Wei F, Rolnick SJ, et al. Geriatric depression, antidepressant treatment, and healthcare utilization in a health maintenance organization. J Am Geriatr Soc. 2002;50: 30712.
  • 21
    Koenig HG, Kuchibhatla M. Use of health services by hospitalized medically ill depressed elderly patients. Am J Psychiatry. 1998;155: 8717.
  • 22
    Druss BG, Rosenheck RA, Sledge WH. Health and disability costs of depressive illness in a major U.S. corporation. Am J Psychiatry. 2000;157: 12748.
  • 23
    Savoca E. Psychiatric co-morbidity and hospital utilization in the general medical sector. Psychol Med. 1999;29: 45764.
  • 24
    Cuffel BJ, Goldman W, Schlesinger H. Does managing behavioral health care services increase the cost of providing medical care? J Behav Health Serv Res. 1999;26: 37280.
  • 25
    Rosenheck RA, Druss B, Stolar M, Leslie D, Sledge W. Effect of declining mental health service use on employees of a large corporation. Health Aff (Millwood). 1999;18: 193203.
  • 26
    Trudeau JV, Deitz DK, Cook RF. Utilization and cost of behavioral health services: employee characteristics and workplace health promotion. J Behav Health Serv Res. 2002;29: 6174.
  • 27
    Buck JA, Teich JL, Bae J, Dilonardo J. Mental health and substance abuse services in ten state Medicaid programs. Adm Policy Ment Health. 2001;28: 18192.
  • 28
    Buck JA, Teich JL, Miller K. Use of mental health and substance abuse services among high-cost Medicaid enrollees. Adm Policy Ment Health. 2003;31: 314.
  • 29
    Rost K, Smith R, Matthews DB, Guise B. The deliberate misdiagnosis of major depression in primary care. Arch Fam Med. 1994;3: 3337.
  • 30
    Waxman HM, McCreary G, Weinrit RM, Carner EA. A comparison of somatic complaints among depressed and non-depressed older persons. Gerontologist. 1985;25: 5017.
  • 31
    Passamonti M, Pigni M, Fraticelli C, Calori G, Piccinelli M. Somatic symptoms and depression in general practice in Italy. Eur J Gen Pract. 2003;9: 667.
  • 32
    Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341: 132935.
  • 33
    Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res. 2003;12: 3443.
  • 34
    Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry. 1993;150: 73441.
  • 35
    Katon W. Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs. J Clin Psychiatry. 1996;57 (suppl 10): 118; discussion 19–22.
  • 36
    Khan AA, Khan A, Harezlak J, Tu W, Kroenke K. Somatic symptoms in primary care: etiology and outcome. Psychosomatics. 2003;44: 4718.
  • 37
    Kroenke K, Price RK. Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med. 1993;153: 247480.
  • 38
    Katon W, Sullivan M, Walker E. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med. 2001;134 (pt 2): 91725.
  • 39
    Morris JA Jr, Carrillo Y, Jenkins JM, et al. Surgical adverse events, risk management, and malpractice outcome: morbidity and mortality review is not enough. Ann Surg. 2003;237: 84451; discussion 851–2.
  • 40
    Thomas EJ, Studdert DM, Burstin HR, et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care. 2000;38: 26171.
  • 41
    Brennan TA. The Institute of Medicine report on medical errors—could it do harm? N Engl J Med. 2000;342: 11235.
  • 42
    Merrick EL, Garnick DW, Horgan CM, Goldin D, Hodgkin D, Sciegaj M. Benefits in behavioral health carve-out plans of Fortune 500 firms. Psychiatr Serv. 2001;52: 9438.
  • 43
    Goldman W, McCulloch J, Sturm R. Costs and use of mental health services before and after managed care. Health Aff (Millwood). 1998;17: 4052.
  • 44
    Scheffler RM. Managed behavioral health care and supply-side economics. 1998 Carl Taube Lecture. J Ment Health Policy Econ. 1999;2: 218.
  • 45
    Matevia ML, Poon D, Goldman W, Cuffel B, McCulloch J. Access to network clinicians in a managed behavioral health organization. Psychiatr Serv. 2001;52: 1428.
  • 46
    U.S. General Accounting Office. Private Health Insurance. Access to Individual Market Coverage May Be Restricted for Applicants with Mental Disorders. Report No. GAO-02–339. Washington, DC: U.S. General Accounting Office; 2002.